Article

The impact of psychological treatment on catastrophization and pharmacological response in chronic migraine: A single-center experience

2024-11-08

Abstract excerpt

<h4>A bstract </h4> <h4>Background</h4> We aimed to assess the impact of pain catastrophizing, measured using the Italian version of the Pain Catastrophizing Scale (PCS), on the clinical response of patients with chronic migraine to anti-CGRP monoclonal antibodies combined with a multidisciplinary approach, including psychological treatment. <h4>Methods</h4> 25 Outpatients from SS. Antonio e Biagio e Cesare Arrigo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1dec5dd0-e463-5bf4-90d1-5e3f486ae491
DOI: 10.1101/2024.11.08.24315876

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The impact of psychological treatment on catastrophization and pharmacological response in chronic migraine: A single-center experienceDOI 10.1101/2024.11.08.24315876Read

Psychological Predictors of Negative Treatment Outcome with Erenumab in Chronic Migraine: Data From an Open Label Long-Term Prospective StudySemantic proximity Read

The development and psychometric properties of a self-report Catastrophising QuestionnaireSemantic proximity Read

Onabotulinumtoxin A improves psychological aspects in chronic migraine patientsSemantic proximity Read

Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity Read

Early Improvement of Affective, Fatigue and Allodynic Symptoms in a Cohort of Resistant Migraineurs Treated with Anti-CGRP/R AntibodiesSemantic proximity Read

Real-World experience of interictal burden and treatment in migraine: a qualitative interview studySemantic proximity Read

The Multifaceted Effects of Migraine on Syrian Society: Insights from a Multicenter Cross- Sectional StudySemantic proximity Read

Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity Read

Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity Read

Fremanezumab in the Prevention of High-Frequency Episodic and Chronic Migraine: A 12-Week, Multicenter, Real-Life, Cohort Study (The FRIEND Study).Semantic proximity Read

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read